会议名称：第六届“亚洲药剂学论坛”暨第六届亚洲药物制剂科学杂志编委会扩大会国际论坛

　　会议时间：2023年6月2-4日

　　会议地点：河南省黄河迎宾馆（河南省郑州市惠济区迎宾路1号）

　　会议主办单位：河南省科协

　　会议承办单位：郑州大学

　　参会人员组成及人数：1000人

　　主会场参会专家简介及交流题目：

　　1.阎锡蕴

　　报告题目:纳米酶:新概念，新材料，新应用

　　阎锡蕴，纳米生物学家，中国科学院院士，从事肿瘤等疾病诊疗研究。发现肿瘤新靶点CD146。发现并定义纳米酶，开辟了纳米酶研究新领域，建立了纳米酶研究方法、纳米酶国家和国际标准。获国家自然科学二等奖、Atlas国际奖、谈家桢生命科学成就奖、何梁何利基金科学与技术进步奖、全国创新争先奖状、三八红旗手标兵等。

　　2.张志荣

　　报告题目:纳米递药系统成药的基础科学问题

　　张志荣，博士(导师)，国家杰出青年科学基金获得者、享受政府特殊津贴专家、国家“百干万人才工程”一、二层次人选。现任四川大学华西药学院教授，国家仿制药质量和疗效一致性评价专家委员会成员，中国药学会工业药剂学专委会委员主要从事药物递释系统研究和新药研发。近20年，主持国家自然科学基金重大、重点和面上项目13项;主持国家973计划课题1项、863计划课题2项、国家重大科技专项“重大新药创制”项目2项。以第一或通讯作者发表研究论文400余篇，其中在Nature Communications、Cell Research、Advanced Materials、Advanced Functional Materials、Biomaterials、J.Control.Rel.等SCl收录杂志发表140余篇。主编、副主编出版著作12部。获授权国家发明专利15项。获国家科技进步奖二等奖1项(第一完成人)、四川省自然科学和科技进步奖一等奖5项。指导的博士生获全国百篇优秀博士论文奖1篇。主研新药10余个其中3个载入《中国药典》和《国家基本药物目录》。

　　3.陆伟跃

　　报告题目:脑部肿瘤靶向递药策略与实践

　　陆伟跃，药剂学博士，复旦大学特聘教授(二级教授)，上海泰镇生物技术有限公司创始人，973项目首席科学家、全国优秀博士学位论文指导教师，享受国务院政府特殊津贴。兼任中国药学会常务理事和战略发展专家委员会委员，中国药学会药剂专业委员会主任委员，国家药品注册审评专家咨询委员会委员，克服递药屏障高端制剂全国重点实验室主任等。在药物靶向策略及新型药物制剂研究与开发方面，主持国家重大科学研究计划项目(973项目)“用于脑部肿瘤治疗的新型纳米药物研究”、国家重大新药创制科技专项“新制剂与新释药系统技术平台建设项目、国家自然科学基金重大项目课题“生物大分子药物高效递送系统的递送机制”、国家863项目“肿瘤智能靶向材料叶酸-聚乙二醇研制及其纳米给药系统构建”、上海市教委重大项目“脑胶质瘤的全程靶向递药策略与验证”等国家及省部级科研基金项目26项;获得国内外发明专利授权32项(转让和许可6项)、新药证书2项和临床批件1项;发表SCI论文198篇;指导研究生在“脑胶质瘤靶向策略及递药系统研究”方向获全国百篇优秀博士学位论文奖2次、上海市优秀博士学位论文奖3次;曾获教育部、上海市、中华医学会、中国药学会、上海市药学会等科技奖和上海市育才奖等20余项。

　　4.李亚平

　　报告题目:提高难溶性药物体内递送效率的制剂关键技术及应用

　　李亚平，中国科学院上海药物研究所研究员，药物制剂研究中心主任，国家基金委创新群体和科技部重点领域创新团队学术带头人，杰青，万人计划领军人才，上海科技精英，973和国家重点研发计划项目首席科学家。兼任中国抗癌协会纳米肿瘤学专业委员会主任委员，中国药学会纳米药物专业委员会副主任委员。主要从事纳米制剂，创新递药技术研究与新药开发。提出“精准递送+智能释药”一体化的抗癌药物载体设计新理念，实现了克服肿瘤免疫耐受和化疗耐药的重大突破;开拓了纳米药物抗肿瘤转移研究新方向;创新了提高难溶性药物和核酸药物体内递送效率的制剂技术;创建了改善候选新药成药性的制剂解决方案。在Nat Nanotechnol,Scilmmunol，Adv Mater等期刊发表论文250余篇，他引16,900余次，22篇入选ESI高被引论文，H因子72。入选全球高被引科学家，连续2年列全国药学专家学术影响力百强榜第四名(2021/2022)。主持研发制剂50余种，获新药证书8本，临床批件22件，生产批件16件;获国内外授权专利62件。以第一完成人获国家自然科学二等奖1项，上海科技进步一等奖1项，中国药学会科学技术一等奖2项，以及吴阶平医药创新奖等。

　　5.孙进

　　报告题目:基于前药技术的智能药物递送系统

　　孙进，沈阳药科大学教授，博士生导师，药剂学博士。现任沈阳药科大学药学院院长、无涯创新学院院长、辽宁省药用辅料与包材工程技术研究中心主任和沈阳市生物药剂学重点实验室负责人。先后入选教育部“长江学者特聘教授”、第三批国家“万人计划”、教育部新世纪优秀人才支持计划、科技部中青年科技创新人才、辽宁省特聘教授、辽宁省第七批优秀专家、辽宁省十大科技英才、辽宁省优秀教师，享受国务院政府特殊津贴。主编《口服药物吸收与转运》和《药物转运体》，主译《纳米粒给药系统》。以通讯作者在Nature Communications和Science Advances等领域知名期刊等发表SCI论文300余篇，H-index为48。主持了6项国家自然科学基金，2项科技部重点研发计划，2项国家重大新药创制平台子项目，1项国家辽宁(本溪)新药化基地建设子项目和4项省级课题。获得省科技进步一等奖2项，省科技进步三等奖1项;获得省自然科学学术成果论文一等奖3项;申请专利50项，其中授权30余项;获得新药证书5项，其中一类新药3项。

　　6.张振中

　　报告题目:纳米药物精准递送的基础研究

　　张振中，博士，二级教授，博士生导师“百千万人才工程”国家级人选，国家有突出贡献中青年专家，国务院政府特殊津贴专家，现任郑州大学药学院执行院长，河南省肿瘤重大疾病靶向治疗与诊断重点实验室主任。先后获得河南省科技进步一等奖、二等奖等6项，主持国家自然科学基金8项、国家纳米科技专项1项等。参编教材4部，专著1部。发表高水平论文200余篇，中科院TOP期刊60余篇，IF>10论文30余篇，他引6000余次，多篇进入ESI高被引论文，申请发明专利100余项。连续6年对“药理学与毒理学”学科ESI贡献率排名第一。

国际论坛参会专家介绍：

7. Mingzhong Li

Professor Mingzhong Li has been holding a Chair of Crystallisation Science and Drug Delivery in Leicester School of Pharmacy at De Montfort University (DMU), UK, since 2019.  He obtained his PhD in control and instrumentation engineering from Northeastern University in China. Currently his research interests centre around the fields of crystallisation science and engineering, oral drug formulation design and delivery, and pharmaceutical product manufacturing. He is well acknowledged for his pioneering work of co-crystallisation of active pharmaceutical ingredients for developing patient centric oral medicines for tropical diseases (e.g. malaria, leishmaniasis, and schistosomiasis). His work has been supported by EPSRC (Engineering and Physical Sciences Research Council), GCRF (Global Challenges Research Fund), Royal Society, HEIF (Higher Education Innovation Fund), charities and industries. He is one of the key founding members of Msc Pharmaceutical Quality by Design (QbD) course at DMU, collaborating with experts from international leading pharmaceutical companies and the regulatory bodies. He is also serving as a panel member of the UK Research and Innovation Talent Panel College for supporting to identify the UK’s next generation of research and innovation leaders through the Future Leaders Fellowships, Innovation Scholars and future UKRI collective talent initiatives.

8. 孙逊

Prof. Xun Sun is the Director & Professor of Department of Pharmaceutics, West China School of Pharmacy, Sichuan University. After postdoctoral training at University of Pennsylvania and University of Michigan, she joined the faculty of Sichuan University in 2008 and became a professor in 2012. Prof. Sun’s current research centers on the delivery of biopharmaceuticals, especially for vaccines and nucleic acid-based therapeutics. She has published more than 100 peer-reviewed papers as the corresponding author. She filed 42 patents and contributed chapters to 10 books. She is the Associate Editor of Journal of Controlled Release, Molecular Therapy and Pharmaceutical Fronts. She also serves as the editorial board member of Acta Pharmaceutica Sinica B and the member of Chinese Pharmacopoeia Commission. Prof. Sun was the recipient of the National Science Fund for Distinguished Young Scholars, the Royal Society Newton Advanced Fellowship (UK), the Nagai Foundation Tokyo International Scholarship, the Shulan Medical Prize, the second prize of National Scientific and Technological Progress Award, the first Prize of Sichuan Provincial Science and Technology Progress Award, and Sichuan Youth Award for Science and Technology.

9. Hirofumi Takeuchi:

Dr. Hirofumi Takeuchi is now research professor of Advanced Pharmaceutical Process Engineering (APPEn) and Professor Emeritus (from 2019) of Gifu Pharmaceutical University (GPU). He received his B.S., M.S. and Ph.D in pharmaceutical sciences from Kyoto University. He joined GPU as a faculty member in 1984 and promoted to professor of Pharmaceutical Engineering in GPU. He also worked as the dean of graduate school of GPU (2010-2011) and vice president of GPU (2012-2014). He has also worked as the president of The Academy of Pharmaceutical Science and Technology Japan (2018-19). He is now a chair of a Consortium on Continuous Pharmaceutical Manufacturing Japan (CCPMJ). He is also a Japanese chief editor of Asian Journal of Pharmaceutical Science. One of his research fields is development of liposomal systems focusing at non-invasive drug delivery in pulmonary and ocular administration as well as in oral one. He has also investigated on novel solid dosage form design. Recently he is focusing on promoting continuous pharmaceutical manufacturing. The number of original scientific papers is 314; the number of review papers, book chapters and articles is more than 100. He has received several scientific awards such as the 8th Nagai Award 2008, Hosokawa Powder Technology Foundation Kona Award, 2012, Award for Breakthrough Technology in Drug Delivery System in Asia in 2013, APPIE Japan Award of Technology Development, 2022, The Award of Pharmaceutical Science and Technology, Japan, 2023.

10. 张楠

Nan zhang received her PhD from Syracuse university in new York state on 2013 and became an assistant professor at school of pharmaceutical sciences, zhengzhou university on 2014. She is now associate professor at pharmaceutics department. She has published 40 SCI papers and been granted 11 chinese patents. Her major research inerests are drug delivery systems for arthritis, cancer, wound healing, and scar treatment.

11. 张越

Dr. Yue Zhang currently holds a tenure-track assistant professor position at the School of Engineering in Westlake University. Prior to establishing her own lab, she completed her postdoctoral training with Dr. Gerard C.L Wong at the University of California, Los Angeles, and obtained her PhD under the guidance of Dr. Liangfang Zhang at the University of California, San Diego. Her research focuses primarily on the molecular framework underlying host-pathogen interactions, with a specific emphasis on the engineering of nanodecoys to impede pathogenesis. She has authored 20 papers published in esteemed peer-reviewed journals such as Nature Nanotechnology, Angewandte Chemie International Edition, ACS Nano, and Journal of Controlled Release, among others. Her work has garnered over 2600 citations, earning her a notable h-index of 19. Furthermore, three of her publications have been recognized as top 1% hot papers by ESI. Additionally, Dr. Zhang serves as a junior editor for the Asian Journal of Pharmaceutical Science and contributes as a reviewer for journals like Current Opinion in Solid States and Material Science, Acta Biomaterialia, and Advanced Therapeutics. During her leisure time, she indulges in pursuits such as painting, cooking, and cherishing moments with her baby girl.

12. 孙朋超

Pengchao Sun received her Ph.D. in Chemistry from Karlsruhe Institute of Technology, Germany, and joined Zhengzhou University in 2021. As a growing scientist, she has published more than 10 papers as the first author or the corresponding author in the top journals including Nano Today, Journal of controlled release, Small, and Small Methods ect., in the recent 5 years. Currently, her research focuses on nanocatalytic medicine as well as molecular pharmaceutics.

13. 陈景

Jing Chen is a professor, doctoral supervisor in Nanjing university of Chinese medicine. He was honored as 2022 distinguished professor in Jiangsu province and 2022 young elite scientists by CAST. He was the committee of experimental pharmacology branch of China association of Chinese medicine. He has published around 20 papers in Nature Food, Nature communications, Advanced materials etc. with over 1200 citations.

14. 杨炜静

Weijing Yang is a professor, doctoral supervisor at School of Pharmaceutical Sciences, Zhengzhou University (China). She received her Ph. D. in Chemistry and Physics of Polymers from Soochow University (2017). Then she joined the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at the National Institutes of Health (NIH), as a postdoctoral fellow. In 2021, she moved to Zhengzhou University as a distinguished professor. Her research interests focus on functional nanopaltform construction and cancer immunotherapy. She has published around 20 papers as the first or corresponding author in Journals including Sci. Adv., Adv. Mater., ACS Nano, Nano Today, etc. with over 2600 citations. She serves as the Youth editorial board member of Chinese Chemical Letters, the guest editor of Vaccines. She has been awarded the research grant from National Natural Science Foundation of China (2021). She was honored as Distinguished Professor of Henan Province (2022), High-level talents of Henan Province (2022), 2016 Baxter China Young Investigator Award (First Tier), and received the Central Plains Talent Program Series of Youth Projects (2023).

15. Paul Heng

Paul Heng has a degree in Pharmacy and a PhD degree in pharmaceutical technology from the National University of Singapore (NUS). After graduation, he joined the Department of Pharmacy, NUS where he taught for 38 years and has just retired. Since retiring, he was involved in the establishment of Geanus Technology, Singapore and OneNorth Pharmaceutical Research Centre, Nanjing. His research interest is in pharmaceutical technologies, with focus on encapsulation, specialized delivery systems, particle characterization, compaction and oral solids processing. He has published over 310 international refereed research articles and several book chapters among others. He is the editor-in-chief of the Asian J Pharm Sci and member of several other editorial boards.

16. 王瑞兵

Prof. Wang obtained his BSc and PhD from Jilin University and Queen’s University, Canada, respectively. After obtaining his PhD degree, he sequentially worked as Postdoctoral Fellow in the Department of Chemistry at Queen’s University, Canada, Associate Research Officer at Steacie Institute for Molecular Sciences, National Research Council of Canada, and Senior Scientist for Interventional Medicine R&D at BTG plc (later merged by Boston Scientific), Canada. He joined University of Macau in 2014.

Prof. Wang’s research interest is supramolecular biomaterials, and cell-mimetic and cell-based pharmaceutics. He has published over 200 peer-reviewed research papers on journals such as Nature Comm., Sci. Adv., JACS, Angew, Matter, Adv. Mater., Mater. Today etc, with a total citation of over 8500 times and H-index of 52. He has won several prestigious awards and honors including 2018 Macao Science and Technology Award-Natural Science Award, 2019 UM Teaching Excellence Award, 2020 Macau Science and Technology Award-Technological Invention Award, and 2022 Macau Science and Technology Award-Natural Science Award. He is a grant examiner for National Natural Science Foundation of China (NSFC), French National Research Agency (ANR), Israel Science Foundation (ISF), Czech Science Foundation (GACR), and National Science Centre of Poland (NCN). In addition, he actively serves as Editorial Board Member of Chinese Chemical Letters, and Editorial Advisory Board Member of ACS Applied Bio Materials.

17. 张开翔

Kaixiang Zhang is now a Professor in the School of Pharmaceutical Science, Zhengzhou University. He received his B.S. major in Material Science and Engineering from Tongji University and Ph.D. degree major in Chemistry from Tsinghua University. He joined Zhengzhou University as a faculty member in 2017 and promoted to professor in 2023. His major research interest includes: 1) In situ imaging of gene information using gene editing tools; 2) DNA nanomaterials-based drug delivery and gene therapy. He has published more than 100 papers and got over 4000 citations. Related works were published in Chem. Soc. Rev., J. Am. Chem. Soc., Angew. Chem. Int. Ed., Adv. Mater., J. Extracell. Vesicles, Nano Lett., Chem. Sci., and Anal. Chem. et al.

18. 赵俊

Jun Zhao, PhD, Professor, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology. Dr. Zhao received his Ph.D. from Purdue University, United States, in 2009. He worked as a postdoctoral fellow and then an instructor at the University of Texas MD Anderson Cancer Center from 2009 to 2019. He joined the faculty at Huazhong University of Science and Technology in 2019. His latest research focused on the development of novel diagnostic and therapeutic agents for pancreatic cancer, including (1) to understand the biological effects of irreversible electroporation; (2) to develop effective drug delivery tools for pancreatic cancer; and (3) to develop nuclear imaging probes for predicting the efficacy of immunotherapy. Dr. Zhao has published 15 papers in high-impact journals during the last five years, including Nature Communications, Advanced Science, and ACS Nano. He has been awarded two research grants from the National Natural Science Foundation of China, and was elected in "100 Talents Program of Hubei Province" and "Distinguished Young Scholars of Hubei Province".

19. Ayesha Younas

Ayesha Younas received her degree of Doctor of Pharmacy (2008-2013) and M.Phil. Pharmaceutics (2015-2017) from The University of Lahore, Lahore, Pakistan. She also worked in the industrial sector as a Quality assurance inspector and production pharmacist. She recently completed her doctoral studies in pharmaceutics (Ph.D. Pharmaceutics) from School of Pharmaceutical Sciences, Zhengzhou University, China. In her doctoral degree, her main focus was on knee injuries, infectious wound healing, and hypertrophic scar treatment by developing nanomedicine, and microneedles-based drug delivery system. She demonstrated exceptional skills in designing and conducting experiments, analyzing data, and presenting results. Her contributions to the research were invaluable and led to the publication of several research articles in peer-reviewed journals. She authored and co-authored 8 papers in highly reputed journals like Carbohydrate Polymers, International Journal of Pharmaceutics, Coordination Chemistry Reviews, and Journal of Controlled Release, etc. In April 2023, the School of Basic Medicine at Zhengzhou University, China, recruits her as a post-doctoral candidate due to her remarkable credentials, skills, and contributions to drug delivery research.

供稿人：郑州大学药学院